Medical Devices — Total Assets
Business Segments · Total AssetsJohnson & Johnson Medical Devices — Total Assets decreased by 0.3% to $86.50B in Q3 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ4 2018
Last reportedQ3 2025
Rolls up toTotal Assets
How to read this metric
Growth in assets generally supports future revenue expansion, provided the return on those assets remains stable.
Detailed definition
This represents the total book value of resources owned or controlled by the medical technology segment, including inven...
Peer comparison
Standard segment-level balance sheet metric for diversified industrial and healthcare companies.
Metric ID:
jnj_segment_medtech_assetsHistorical Data
7 periods
| Q1 '22 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $53.37B | $70.96B | $74.71B | $84.32B | $85.11B | $86.75B | $86.50B |
| QoQ Change | — | +32.9% | +5.3% | +12.9% | +0.9% | +1.9% | -0.3% |
| YoY Change | — | — | +5.3% | +12.9% | — | — | — |
Range$53.37B – $86.75B
CAGR+38.0%
Avg YoY Growth+9.1%
Median YoY Growth+9.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medical devices — total assets?
- Johnson & Johnson (JNJ) reported medical devices — total assets of $86.50B in Q3 2025.
- What does medical devices — total assets mean?
- The total value of all resources and assets dedicated to the medical technology business.